Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have become a major concern in the containment of current pandemic. The variants, including B.1.1.7 (Alpha), B.1.351 (Beta), P1 (Gamma) and B.1.617.2 (Delta) have shown reduced sensitivity to monoclonal antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrestha, Lok Bahadur, Tedla, Nicodemus, Bull, Rowena A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502962/
https://www.ncbi.nlm.nih.gov/pubmed/34646276
http://dx.doi.org/10.3389/fimmu.2021.752003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502962/
https://www.ncbi.nlm.nih.gov/pubmed/34646276
http://dx.doi.org/10.3389/fimmu.2021.752003

Ejemplares similares